In vivo Magnetofection has been designed for in vivo targeted transfection and transduction. This original system combines magnetic nanoparticles and nucleic acid vectors that are retained after injection at the magnetically targeted site. In this way, systemic distribution is minimized and toxicity is reduced.
Several specialized reagents have been developed:
Starter kits and trial kits that include magnet sets are available for select reagents. The magnet sets are sold separately as well.